Profil
Adam Shilling worked as an Executive Director of Global Regulatory Affairs at Incyte Corp.
He then worked as a Vice President of Early Development at Prelude Therapeutics, Inc. from 2019 to 2022.
Mr. Shilling received an undergraduate degree from Long Island University and a doctorate degree from Oregon State University.
Anciens postes connus de Adam Shilling
| Sociétés | Poste | Fin |
|---|---|---|
| PRELUDE THERAPEUTICS INCORPORATED | General Counsel | 01/04/2022 |
| INCYTE CORPORATION | General Counsel | - |
Formation de Adam Shilling
| Long Island University | Undergraduate Degree |
| Oregon State University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
14
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| INCYTE CORPORATION | Health Technology |
| PRELUDE THERAPEUTICS INCORPORATED | Health Technology |
